Tirzepatide + Retatrutide 60 mg

TR-2026-001Lot NOT PROVIDEDAnalyzed November 3, 2026

Timeline

Ordered

October 28, 2026

Received

November 2, 2026

Analyzed

November 3, 2026

Sample

Name

Tirzepatide + Retatrutide 60 mg

Expected

Tirzepatide + Retatrutide

Amount

1 vial, lyophilized powder

Testing

Client

4Ever Research

Test type

Content & purity

Method

HPLC-UV

Content, how much is in it

Tirzepatide37.28mg

Label claim: 40 mg

Retatrutide25.15mg

Label claim: 20 mg

Purity, how clean it is

99.5%

by HPLC-UV peak area, system peaks excluded

Chromatogram

HPLC-UV

18.06 min, Retatrutide

18.81 min, Tirzepatide

Analyst Comments

White lyophilized powder, clear-cap vial, received sealed.

Analyst Signature

Max Barrett

Lab Director, PuriLab Analytical

Analysis date: November 3, 2026

Verification Code

TR-7FI7-CZ6K

Verify at purilab.org/verify/TR-7FI7-CZ6K

Scan to Verify

TR-7FI7-CZ6K

Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.

PuriLab Analytical|admin@purilab.org

Page 1 of 1